샘플 요청 목록

 카트 문의
시장보고서
상품코드
1551639

좌심방이(LAA) 폐쇄 디바이스 시장

Left Atrial Appendage (LAA) Closure Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 286 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

좌심방이(LAA) 폐쇄 디바이스세계 시장은 2030년까지 56억 달러에 달할 것으로 전망

2023년 20억 달러로 추정되는 좌심방이(LAA) 폐쇄 디바이스세계 시장은 2023-2030년의 분석 기간 동안 연평균 16.3% 성장하여 2030년에는 56억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 심내막 LAA 장치는 CAGR 16.8%를 기록하여 분석 기간 종료 시점에 47억 달러에 도달할 것으로 예상됩니다. 심외막 LAA 장치 부문은 분석 기간 동안 13.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 추정됩니다.

미국 시장 5억 3,220만 달러로 추정, 중국은 CAGR 21.7%로 성장 전망

미국 좌심방이(LAA) 폐쇄 디바이스 시장은 2023년 5억 3,220만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 13억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 21.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 12.3%와 14.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 약 13.0%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 좌심방이(LAA) 폐쇄 디바이스시장 - 주요 동향 및 촉진요인 요약

좌심방이(LAA) 폐쇄장치란 무엇이며, 왜 중요한가?

좌심방이(LAA) 폐쇄 디바이스는 일반적인 심장 리듬 장애 인 심방 세동(AF) 환자의 뇌졸중 위험을 줄이기 위해 고안된 특수 의료 도구로, LAA는 심장의 좌심방에 위치한 작은 귀 모양의 주머니로, 심방 세동 환자의 불규칙한 혈류로 인해 혈전이 형성되기 쉽습니다. 이 혈전이 뇌에 도달하면 뇌졸중을 일으킬 수 있습니다. 기존에는 심방세동 환자의 뇌졸중 예방은 혈전 형성을 억제하는 항응고제에 의존해 왔습니다. 그러나 출혈성 합병증의 위험으로 인해 모든 환자가 이러한 약물을 견딜 수있는 것은 아니며, LAA 폐쇄 디바이스는 LAA를 물리적으로 폐쇄하여 혈전이 혈류로 유입되어 뇌졸중을 유발하는 것을 방지하는 대안을 제공합니다. 이 치료법은 뇌졸중 위험이 높지만 항응고제를 장기간 안전하게 복용할 수 없는 환자에게 특히 중요합니다. 따라서 LAA 폐쇄 디바이스는 심방세동 관리에 있어 점점 더 중요한 선택이 되고 있으며, 점점 더 많은 환자들에게 생명을 구할 수 있는 해결책을 제공합니다.

기술의 발전은 어떻게 LAA 폐쇄 디바이스를 향상시켰습니까?

기술의 발전으로 좌심방세동 폐쇄장치의 디자인, 안전성, 유효성이 크게 향상되었습니다. 최신 장치는 일반적으로 이식형이며, 최소 침습적 카테터 시술로 제공됩니다. 이 시술은 장치를 혈관을 통해 심장에 삽입한 후, 장치를 확장하여 LAA를 폐쇄하는 방식으로 이루어집니다. 이러한 시술은 경식도 심초음파나 투시 등 첨단 영상 기술을 통해 유도되어 장치를 정확하게 배치할 수 있습니다. 또한, 장치의 재료와 공학적인 개선을 통해 LAA의 해부학적 구조에 더 잘 맞도록 더 작고, 더 유연하며, 더 생체 적합성이 높은 장치가 개발되어 장치 색전증이나 불완전한 폐쇄와 같은 합병증의 위험을 줄일 수 있습니다. 또한, 차세대 장치는 회수 및 재배치가 가능하도록 설계되어 시술 중 조작성을 높이고 환자의 안전성을 더욱 향상시킬 수 있습니다. 이러한 기술 혁신은 LAA 폐쇄술의 대상 환자를 확대하고 임상 결과를 개선하는 데 기여하고 있으며, 심방세동 환자의 뇌졸중 예방에 있어 보다 실용적이고 매력적인 선택이 되고 있습니다.

의료진과 환자가 LAA 폐쇄 디바이스에 주목하는 이유는 무엇인가?

장기 항응고 치료의 한계에 대한 인식이 높아지면서 보다 안전하고 효과적인 뇌졸중 예방 옵션을 찾는 의료진과 환자들 사이에서 LAA 폐쇄장치에 대한 관심이 높아지고 있습니다. 심방세동 환자의 상당수가 출혈 위험이 높거나 항응고제 부작용을 경험하고 있어 삶의 질과 전반적인 건강에 큰 영향을 미칠 수 있는데, LAA 폐쇄 디바이스는 일회성 저침습적 치료로 지속적인 약물 치료 없이도 뇌졸중 위험을 크게 낮출 수 있습니다. 수 있습니다. 의료진에게 이 장치는 광범위한 환자, 특히 항응고제가 금기인 환자의 뇌졸중 위험을 관리하는 데 중요한 도구가 될 수 있습니다. 경피적으로 시술할 수 있고, 회복 시간이 비교적 짧고, 입원 기간을 최소화할 수 있어 LAA 폐쇄 디바이스의 매력은 더욱 커지고 있습니다. 이 시술이 더 널리 채택되고 임상 데이터에서 그 효과와 안전성이 계속 입증됨에 따라, 환자와 의료진 모두 LAA 폐쇄술을 심방세동에서 뇌졸중을 예방하기 위한 최선의 전략으로 고려하고 있습니다.

LAA 폐쇄 디바이스 시장의 성장을 가속하는 요인은 무엇인가?

좌심방세동 폐쇄 디바이스 시장의 성장은 심혈관 치료 및 환자 관리의 광범위한 추세를 반영하는 몇 가지 중요한 요인에 의해 주도되고 있습니다. 주요 요인은 전 세계적으로 심방세동 유병률이 증가하고 있으며, 특히 심방세동과 뇌졸중에 취약한 고령화 사회에서 증가하고 있습니다. 심방세동 환자 수가 증가함에 따라 효과적인 뇌졸중 예방 전략에 대한 필요성이 높아지면서 LAA 폐쇄장치에 대한 수요도 증가하고 있습니다. 보다 효과적이고 안전하며 사용하기 쉬운 장치 개발 등 장치 기술의 발전은 이러한 시술 대상 환자군을 확대함으로써 시장 개척에 박차를 가하고 있습니다. 또한, 출혈성 합병증과 같은 장기 항응고 치료의 한계와 위험으로 인해 환자와 의사 모두 다른 뇌졸중 예방법을 찾고 있으며, 이는 LAA 폐쇄 디바이스의 채택을 더욱 촉진하고 있습니다. 또한, 외래 환자를 포함한 다양한 의료 환경에서 LAA 폐쇄술이 가능해짐에 따라 환자들에게 LAA 폐쇄술이 더욱 친숙해져 시장 확대에 기여하고 있습니다. 또한, LAA 폐쇄술의 안전성과 유효성을 뒷받침하는 임상적 증거 증가와 많은 지역에서 유리한 상환 정책으로 인해 의사들의 신뢰와 환자들의 수용이 강화되어 향후 몇 년동안 이 장치들 시장은 지속적으로 성장할 것으로 예상됩니다.

조사 대상 기업 예시(총 52건)

  • Abbott Laboratories
  • Acutus Medical Inc.
  • AtriCure, Inc.
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • Carag AG
  • Cardia, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology（Beijing）Co.
  • LifeTech Scientific Corporation
  • Occlutech International AB

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.09.20

Global Left Atrial Appendage (LAA) Closure Devices Market to Reach US$5.6 Billion by 2030

The global market for Left Atrial Appendage (LAA) Closure Devices estimated at US$2.0 Billion in the year 2023, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 16.3% over the analysis period 2023-2030. Endocardial LAA Devices, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Epicardial LAA Devices segment is estimated at 13.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$532.2 Million While China is Forecast to Grow at 21.7% CAGR

The Left Atrial Appendage (LAA) Closure Devices market in the U.S. is estimated at US$532.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 21.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.3% and 14.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Left Atrial Appendage (LAA) Closure Devices Market - Key Trends and Drivers Summarized

What Are Left Atrial Appendage (LAA) Closure Devices and Why Are They Critical?

Left Atrial Appendage (LAA) closure devices are specialized medical tools designed to reduce the risk of stroke in patients with atrial fibrillation (AF), a common heart rhythm disorder. The LAA is a small, ear-shaped pouch in the left atrium of the heart where blood clots are likely to form in patients with AF, due to irregular blood flow. If these clots travel to the brain, they can cause a stroke. Traditionally, stroke prevention in AF patients has relied on anticoagulant medications to reduce blood clot formation. However, not all patients can tolerate these drugs due to the risk of bleeding complications. LAA closure devices offer an alternative by physically sealing off the LAA, thereby preventing clots from entering the bloodstream and causing a stroke. This intervention is especially critical for patients who are at high risk of stroke but cannot safely take long-term anticoagulants. As such, LAA closure devices are becoming an increasingly vital option in the management of atrial fibrillation, offering a potentially life-saving solution for a growing patient population.

How Have Advances in Technology Enhanced LAA Closure Devices?

Technological advancements have significantly improved the design, safety, and efficacy of Left Atrial Appendage closure devices. Modern devices are typically implantable and delivered through minimally invasive catheter-based procedures, which involve threading the device through the blood vessels to the heart, where it is then deployed to seal the LAA. These procedures are guided by advanced imaging technologies, such as transesophageal echocardiography and fluoroscopy, which allow for precise placement of the device. Improvements in device materials and engineering have also led to the development of smaller, more flexible, and more biocompatible devices that conform better to the anatomy of the LAA, reducing the risk of complications such as device embolization or incomplete closure. Additionally, newer-generation devices are designed to be retrievable and repositionable, providing the operator with more control during the procedure and further enhancing patient safety. These innovations have expanded the patient eligibility for LAA closure procedures and have contributed to better clinical outcomes, making these devices a more viable and attractive option for stroke prevention in AF patients.

Why Are Healthcare Providers and Patients Turning to LAA Closure Devices?

The growing interest in LAA closure devices among healthcare providers and patients is driven by the increasing awareness of the limitations of long-term anticoagulant therapy and the desire for safer, more effective stroke prevention options. Many patients with atrial fibrillation are either at high risk of bleeding or experience adverse effects from anticoagulant medications, which can significantly impact their quality of life and overall health. LAA closure devices offer a one-time, minimally invasive alternative that can dramatically reduce the risk of stroke without the need for ongoing medication, which is particularly appealing to patients who are concerned about the long-term use of blood thinners. For healthcare providers, these devices provide a critical tool in managing stroke risk in a broader range of patients, particularly those who are contraindicated for anticoagulants. The ability to perform the procedure percutaneously, with relatively quick recovery times and minimal hospital stays, further enhances the appeal of LAA closure devices. As the procedure becomes more widely adopted and as clinical data continue to demonstrate its efficacy and safety, both patients and providers are increasingly considering LAA closure as a preferred strategy for stroke prevention in atrial fibrillation.

What Factors Are Driving the Growth of the LAA Closure Devices Market?

The growth in the Left Atrial Appendage closure devices market is driven by several key factors, reflecting broader trends in cardiovascular care and patient management. A primary driver is the increasing prevalence of atrial fibrillation worldwide, particularly among the aging population, which is more susceptible to both AF and stroke. As the number of AF patients rises, so too does the need for effective stroke prevention strategies, thereby fueling demand for LAA closure devices. Advances in device technology, including the development of more effective, safer, and easier-to-use devices, have also spurred market growth by expanding the patient population eligible for these procedures. Additionally, the limitations and risks associated with long-term anticoagulant therapy, such as bleeding complications, have led both patients and physicians to seek alternative stroke prevention methods, further driving the adoption of LAA closure devices. The increasing availability of these procedures in a wider range of healthcare settings, including outpatient facilities, has made them more accessible to patients, contributing to market expansion. Furthermore, growing clinical evidence supporting the safety and efficacy of LAA closure, along with favorable reimbursement policies in many regions, has bolstered both physician confidence and patient acceptance, ensuring continued growth in the market for these devices in the coming years.

Select Competitors (Total 52 Featured) -

  • Abbott Laboratories
  • Acutus Medical Inc.
  • AtriCure, Inc.
  • Biosense Webster, Inc.,
  • Boston Scientific Corporation
  • Carag AG
  • Cardia, Inc.
  • Johnson & Johnson Services, Inc
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • LifeTech Scientific Corporation
  • Occlutech International AB;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Left Atrial Appendage (LAA) Closure Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Implantable Device Technology Propel Growth in LAA Closure Devices
    • Increasing Prevalence of Atrial Fibrillation Expands Addressable Market Opportunity for LAA Closure
    • Integration of Imaging and Navigation Systems Strengthens the Business Case for Precision in LAA Closure Procedures
    • Growing Patient Preference for Minimally Invasive Procedures Drives Adoption of LAA Closure Solutions
    • Technological Innovations in Device Design Spur Growth in Safety and Efficacy of LAA Closure
    • Rising Awareness of Stroke Prevention in AF Patients Generates Demand for LAA Closure
    • Focus on Long-Term Outcomes and Reduced Anticoagulant Dependency Sustains Growth in LAA Closure Market
    • Challenges in Procedural Costs and Access Create Opportunities for Innovation in Affordable LAA Closure Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Left Atrial Appendage (LAA) Closure Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Endocardial LAA Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Endocardial LAA Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Endocardial LAA Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Epicardial LAA Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Epicardial LAA Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Epicardial LAA Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Left Atrial Appendage (LAA) Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Left Atrial Appendage (LAA) Closure Devices by Device Type - Endocardial LAA Devices and Epicardial LAA Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by Device Type - Percentage Breakdown of Value Sales for Endocardial LAA Devices and Epicardial LAA Devices for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Left Atrial Appendage (LAA) Closure Devices by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Left Atrial Appendage (LAA) Closure Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제